
The new study in Diabetes Care comes more than a year after the initial results of the TECOS trial were presented at the American Diabetes Association Scientific Sessions.
Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (AJMC®). She joined AJMC® in 2013 and is the primary staff editor for Evidence-Based Oncology, the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for AJMC®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for AJMC readers.
Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on LinkedIn.

The new study in Diabetes Care comes more than a year after the initial results of the TECOS trial were presented at the American Diabetes Association Scientific Sessions.

The study found that, if anything, children with private coverage are being admitted to the hospital too often, raising questions about the allocation of healthcare resources.

The new definition applies to CGM devices that have FDA approval for dosing decisions. Right now, Dexcom's G5 meets the 5-part test.

The World Health Organization has called for limiting soda marketing to kids, and the authors describe the holiday truck as a item that needs to go.

If the Affordable Care Act is repealed, providers of the Diabetes Prevention Program will need to replace the path to Medicare reimbursement that were covered in the law.

The governor's plan takes aim at prior authorization from insurers and seeks a prescription cap of a 5-day supply, which would be stricter than the revamped CDC guidelines.

Director Tom Frieden, MD, MPH, said the results show that a population health—based approach can save lives and money when there are "rigorous" standards for accountability.

The ruling means that barring a settlement or a reversal on appeal, Sanofi and Regeneron could be forced to stop selling Praluent within 6 weeks.

The addition of new a chief medical officer and a new chief commercial officer comes as the digital health provider is poised to scale up delivery of the National Diabetes Prevention Program in Medicare.

During an interview with Vox that was simulcast by the White House, President Barack Obama reviews where his signature law is working, where it isn't, and why Americans should demand to see what a replacement would look like.

The judge's ruling allows 30 days for an appeal but encourages the parties to work out a settlement. The case involves competing, expensive drugs to control cholesterol.

There are signs that some Republicans are uncomfortable with repealing President Barack Obama's signature law without taking steps to keep those who gained coverage from becoming uninsured.

The intervention involves limiting carbohydrates to 40% of calories and having participants maintain muscle mass, so energy levels remain high.

Contrary to popular opinion, hospitals that receive lower reimbursements from public programs often cut fees to private payers to adjust to the new normal. Medicaid expansion, in particular, has had a net positive effect because hospitals are faced with less uncompensated care.

The groups represent nearly 400,000 practitioners on the front lines of primary care for families, women, and children.

The American College of Physicians' oral medication guideline for treating type 2 diabetes is the first update since 2012, and it reflects many new medications that have received FDA approval since that time.

Like others, we were surprised by Trump's victory, but our coverage predicted problems for the Medicare Part B proposal, and we wrote early on about the growing outrage over insulin prices.

Why a mobile health coaching company sees its move from per member per month to outcomes-based payment as the right thing-for employers and for consumers.

Important updates of the past year sought to recognize the importance of obesity care and the need to better integrate behavioral health into diabetes care.

The American Journal of Managed Care provides coverage from its live meetings, the ACO & Emerging Healthcare Delivery Coalition, Patient-Centered Oncology Care, and Patient-Centered Diabetes Care.

Delays in seeking medical care are one explanation for the "Christmas effect."

Inflammation appears to be the reason patients living with HIV have higher heart disease risk.

There's no shortage of reader interest in Afrezza-the inhaled, meal-time insulin from MannKind-despite reports from Wall Street that the prescription count is climbing slowly.

The study drug targets both the SGLT1 protein, which affects blood glucose absorption in the gastrointestinal tract, and the SGLT2 protein, which affects reabsorption by the kidney.

The report seeks discussion of controversial policy solutions, including temporarily importing drugs.

On the day of the approval, top FDA and CMS officials write in JAMA of the need to share data for better healthcare delivery.

The findings come as CMS targets cardiac procedures in both its hospital readmission reduction program and in a bundled payment model set to take effect July 1, 2017.

The findings confirm other studies that show differences in the practice patterns between male and female physicians.

The recommendation to limit long periods of sitting comes after multiple studies show how it affects blood glucose management. ADA also gives providers charts to help them understand the cost of different therapies.

The number of deaths from drug overdoses in 2015 exceeded that of the prior year, which was already the highest on record.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
